EUVIMEDEUVIMED entdecken
Crossref

Docetaxel-Loaded Electrospun Nanofibrous Mats for Local Chemotherapy Targeting Positive Surgical Margins in Prostate Cancer

Xing Li iD, Kun Yuan, Yisheng Yin, Yiqun Tian, Zihao Guo, Zhenliang Qin, Xiaoyong Zeng

Molecular Pharmaceutics · 07.04.2025 · 22 (4) · 2213-2223

DOI: 10.1021/acs.molpharmaceut.4c01440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 12.03.2025. Verfasst von Xing Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department and Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Docetaxel, Prostatic Neoplasms, Nanofibers, Antineoplastic Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Positive surgical margins following radical prostatectomy significantly contribute to tumor recurrence. While systemic chemotherapy demonstrates limited efficacy in this context, local chemotherapy drug delivery systems based on nanomaterials offer promising strategies to address this issue by modifying drug release kinetics and distribution, thereby enhancing antitumor effects while minimizing the toxicities associated with systemic chemotherapy. In this study, we utilized electrospun nanofibrous mats loaded with docetaxel for sustained drug delivery. In vitro experiments demonstrated that these implantable drug-loaded nanofibrous mats effectively inhibited prostate cancer cell growth, induced cell cycle arrest, and promoted apoptosis. In animal models, these drug-loaded nanofibrous mats exhibited prominent therapeutic effects on positive surgical margins postoperatively. Importantly, docetaxel-loaded nanofibrous mats modulated the tumor immune microenvironment by suppressing M2-like macrophages, increasing the ratio between M1- and M2-like macrophages, and enhancing CD8+ T-cell infiltration. Local administration significantly reduced systemic toxicity compared to systemic chemotherapy. In summary, we developed an implantable electrospun drug-loaded nanofibrous mat for localized docetaxel delivery, which offers a prospective strategy for managing positive surgical margins after surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelProstatic NeoplasmsNanofibersAntineoplastic AgentsMaleAnimalsHumansMiceCell Line, TumorTumor MicroenvironmentDrug Delivery SystemsMargins of ExcisionApoptosisDrug LiberationXenograft Model Antitumor AssaysCell ProliferationMacrophages

Stichwörter der Autor:innen

chemotherapynanofiberspositive surgical marginsprostate cancertumor microenvironment

Substanzen

DocetaxelAntineoplastic Agents

Autor:innen und Institutionen

  • Department and Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

ORCID-Profile: Xing Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, X., Yuan, K., Yin, Y., Tian, Y., Guo, Z., Qin, Z., & Zeng, X. (2025). Docetaxel-Loaded Electrospun Nanofibrous Mats for Local Chemotherapy Targeting Positive Surgical Margins in Prostate Cancer. Molecular Pharmaceutics, 22(4), 2213-2223. https://doi.org/10.1021/acs.molpharmaceut.4c01440

Vancouver

Li X, Yuan K, Yin Y, Tian Y, Guo Z, Qin Z, et al. Docetaxel-Loaded Electrospun Nanofibrous Mats for Local Chemotherapy Targeting Positive Surgical Margins in Prostate Cancer. Molecular Pharmaceutics. 2025;22(4):2213-2223. doi:10.1021/acs.molpharmaceut.4c01440

BibTeX
@article{Li2025,
  author = {Li, Xing and Yuan, Kun and Yin, Yisheng and Tian, Yiqun and Guo, Zihao and Qin, Zhenliang and Zeng, Xiaoyong},
  title = {Docetaxel-Loaded Electrospun Nanofibrous Mats for Local Chemotherapy Targeting Positive Surgical Margins in Prostate Cancer},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {4},
  pages = {2213--2223},
  doi = {10.1021/acs.molpharmaceut.4c01440}
}
Kostenlos starten →